Marpai Health
在场
Marpai Health 是一家在股票代码 MRAI (US) 下上市的公司。
涉及Marpai Health的并购和融资。
- Marpai Health 已收购 Maestro Health (公布2022十一月7号).
高管
查看带有其 14 名主要高管的组织结构图
Marpai Health 搜索最多的简介
- Damien Lamendola, Chief Executive Officer and Director
- Sagiv Shiv, Director
- Yaron Eitan, Chairman of the Board
高管在Marpai Health变化
- Richard Brewer已作为Chief Strategy Officer加入公司 (新闻发布的2024四月25号).
创建提醒
跟踪 Marpai Health 的高管变动
生物技术
Marpai Health 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Marpai Health 的最新新闻稿
- MARPAI ANNOUNCES NEW "OFF CYCLE" CLIENT CONTRACT
- MARPAI PRESIDENT JOHN POWERS TABBED TO SPEAK AT 3 ELITE HEALTHCARE CONFERENCES
- MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
- MARPAI TO HOST WEBCAST ON AUGUST 8, 2024 TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS
- MARPAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
- MARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKET
- MARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASE
- Press Releases
- MARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES
- MARPAI TO HOST WEBCAST ON MAY 10, 2024 TO DISCUSS FIRST QUARTER 2024 FINANCIAL RESULTS
- View more press releases Close
通过电子邮件
